Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS) This pivotal prospective study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results